Calvin Sandra

CIK 00018829091 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001882909

Recent Transactions

50 trades

Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-12-15$36.00/sh−2,910→ 45,635 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-11-04$26.88/sh+17,500→ 81,910 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-11-04−17,500→ 0 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-11-04$36.00/sh−67,115→ 48,545 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-11-04$22.40/sh+12,500→ 109,410 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-11-04−6,250→ 18,750 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-11-04−12,500→ 7,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-11-04−15,000→ 2,500 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-11-04−10,000→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-11-04$8.93/sh+6,250→ 115,660 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-11-04$27.50/sh+15,000→ 96,910 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-11-04$25.25/sh+10,000→ 64,410 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$15.46/sh+15,000→ 78,654 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$17.44/sh+10,000→ 73,654 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-02-11−10,000→ 0 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$25.00/sh−9,244→ 54,410 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$17.96/sh+10,000→ 73,654 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$25.00/sh−15,000→ 63,654 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$25.00/sh−10,000→ 63,654 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$25.00/sh−10,000→ 63,654 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$25.00/sh−10,000→ 63,654 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-11$16.23/sh+10,000→ 73,654 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-02-11−15,000→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-02-11−10,000→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-02-11−10,000→ 0 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-03$20.12/sh−3,348→ 63,654 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-01-31+13,000→ 67,002 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-01-31+26,000→ 26,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-01-22$18.94/sh−925→ 54,002 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2024-12-26−15,000→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-12-26$12.67/sh+15,000→ 69,927 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-12-26$17.22/sh−15,000→ 54,927 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2024-11-25−15,000→ 15,000 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-11-25$12.67/sh+15,000→ 67,017 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-11-25$18.30/sh−12,090→ 54,927 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-02-01$8.53/sh−2,820→ 52,017 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-01-31+1,000→ 54,837 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2024-01-31+25,000→ 25,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-01-31+12,500→ 53,837 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-01-23$9.07/sh−910→ 41,337 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-05-11$16.12/sh−122→ 42,247 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-05-10$16.59/sh−436→ 42,369 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-02-02$22.42/sh−360→ 42,805 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-02-01$21.75/sh−1,671→ 43,165 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-01-31+10,000→ 44,836 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2023-01-31+20,000→ 20,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-01-25$21.63/sh−192→ 34,836 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-01-24$21.90/sh−905→ 35,028 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-09-13$28.00/sh−349→ 35,933 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-05-11$21.92/sh−445→ 35,733 total

Companies

Travere Therapeutics, Inc.
SVP, CHIEF ACCOUNTING OFFICER
$TVTX

Recent Filings

Address

C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DRIVE, SUITE 300

SAN DIEGO, CA, 92130

View on SEC.gov